• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.55 Down 0.11(2.36%) Jan 23, 4:00PM EST
    |After Hours : 4.58 Up 0.03 (0.66%) Jan 23, 7:58PM EST
    Add to Portfolio
    Prev Close:4.66
    Open:4.63
    Bid:3.71 x 200
    Ask:N/A
    1y Target Est:7.67
    Beta:-4.31
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:4.50 - 4.73
    52wk Range:3.26 - 7.38
    Volume:5,306,555
    Avg Vol (3m):7,983,850
    Market Cap:1.00B
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 2.36%1.00B
    GSKUp 0.11%108.20B
    OREXUp 2.46%666.33M
    RHHBYUp 1.82%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback